Osteoarthritis: a new short-term treatment option?

During this time, the understanding of the pathophysiology of osteoarthritis has markedly increased; however, this increased understanding has not yet translated into improved treatment.[1] In fact, there are still few available treatments for osteoarthritis, the most prevalent joint disease worldwide. In The Lancet, Féline Kroon and colleagues[10] report the results of their double-blind, randomised, placebo-controlled trial of daily 10 mg prednisolone in patients with hand osteoarthritis. 10 FPB Kroon, MC Kortekaas, A Boonen, Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial. [Extracted from the article]